Classified under 'Trading - Chemicals', Citichem India Limited operates as a BSE-listed entity dealing in chemical products, though the specific chemicals traded are not named in the filings. Revenue from operations fell nearly 50% in FY26 to Rs 9.48 crore from Rs 18.70 crore in FY25, with total revenue at Rs 15.48 crore versus Rs 54.73 crore (the latter inflated by a one-time Rs 35.20 crore write-back of sundry creditor balances). Profit after tax for FY26 stood at Rs 1.00 crore, down from Rs 1.23 crore, while EPS dropped to Rs 1.47 from Rs 2.46. Related party purchases from associate companies exceeded Rs 10 crore in FY26, suggesting that the bulk of its traded chemical volume flows through inter-group arrangements. The half-year ended September 2025 showed revenue from operations of Rs 8.52 crore against Rs 1.67 crore in H1 FY25, indicating a recovery in core trading activity within the year. Operating cash flow remained negative at Rs 5.19 crore in FY26, though improved from a Rs 11.58 crore loss the prior year, and trade receivables declined from Rs 51.08 crore to Rs 37.17 crore. Listed on the BSE SME platform in January 2025 through an IPO at Rs 70 per share, the company explored a Rs 13.63 crore preferential warrant issue during the year but later withdrew it citing adverse market conditions and lack of in-principle BSE approval. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Trading in chemicals (100%). Small-cap, BSE SME-listed chemicals trading company with thin margins, related-party-heavy sourcing and negative operating cash flow.
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 54 | 15 |
| EBITDA (ex other income) | — | — |
| margin % | — | — |
| Owners' profit | — | — |
| EPS, as reported (₹) | 2.26 | 1.47 |
| ROE % · ROCE % | — · 9.5 | — · 9.3 |
| Debt / equity (x) | — | — |
| Cash from operations | (12) | (5) |
| Capex | (0) | (1) |
| ₹ crore | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|
| Revenue | 2 | 53 | 10 | 5 |
| Profit before tax | 0 | 2 | 1 | 0 |
| Net profit | — | — | — | — |
| EPS (₹) | 0.25 | 2.03 | 1.36 | 0.47 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UNIPHOS ENTERPRISES LTD | 635 | 31.4 | 0.26 | — | 0.8 | 0.8 | — | — |
| VINYL CHEMICALS (I) LTD. | 402 | 17.3 | 3.09 | — | 12.7 | 16.8 | — | 9.0 |
| EVEXIA LIFECARE LIMITED | 310 | 55.0 | 0.71 | 108.2 | 0.4 | 0.3 | 0.7 | 3.3 |
| BHAVIK ENTERPRISES LIMITED | 293 | 19.8 | — | — | — | 11.1 | — | — |
| A-1 LIMITED | 289 | 26.2 | 5.34 | 26.2 | 11.1 | 14.8 | — | 3.5 |
| SHANKAR LAL RAMPAL LTD | 245 | 13.3 | 2.00 | — | 11.0 | 14.7 | — | 9.4 |
| MYSORE PETRO CHEMICALS L | 93 | 17.1 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · Newspaper ad for Citichem India 34th AGM notice and e-voting details | compliance | minimal | — | — |
| 7 Sept 2026 · Annual Report FY 2025-26 filed; 34th AGM set for 30 September 2026 | investor communications | medium | — | — |
| 7 Sept 2026 · Notice of 34th AGM on September 30, 2026 | board shareholder meetings | low | — | — |
| 30 May 2026 · Audited Standalone Financial Results for the Fourth Quarter ended 31st March 2026 | results | high | — | — |
| 30 May 2026 · This is in reference to our earlier intimation dated 26th May, 2026, pursuant to Regulation 29 read with Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing .... | board shareholder meetings | low | — | — |
| 26 May 2026 · Citichem India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Notice is hereby given pursuant .... | results | low | — | — |
| 30 Apr 2026 · <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... | compliance | minimal | — | — |
| 15 Apr 2026 · Please find enclosed herewith the clarification on price movement. | general | low | — | — |
| 13 Apr 2026 · The Exchange has sought clarification from Citichem India Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information .... | regulatory legal | medium | — | — |
| 21 Jan 2026 · As per attached disclosure. | fund raising |
| 0.41 |
| 100.3 |
| 0.4 |
| 0.2 |
| 18.0 |
| (0.4) |
| Yash Chemex Limited | 53 | 24.1 | 0.87 | 14.4 | 4.0 | 5.2 | 20.6 | (0.0) |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 3.1 | 17.2 | 3 of 14 | 85% |
| ROCE | 6.5 | 3.0 | 6 of 14 | 62% |
| Market cap | 9 | 93 | 11 of 13 | 17% |
| medium |
| — |
| — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
